Exact Sciences rises, Abbott falls on $23 billion buyout deal
Shares of cancer test maker Exact Sciences EXAS.O rise 17.2% to $101 while medical device maker Abbott Laboratories ABT.N fell 1.1% to $124.70
ABT, which was one of the weakest stocks in the S&P 500 healthcare index .SPXHC on Thursday, says it will acquire EXAS for up to $23 billion, including $21 billion in equity, to tap into the fast-growing cancer diagnostics segment
Under terms of the deal, ABT will acquire all outstanding shares of EXAS for $105 per share, a premium of 21.8% to EXAS' last closing price before the announcement.
On Wednesday EXAS shares had risen 23.7% after a Bloomberg News report that Abbott was closing in on a deal with EXAS and ABT shares ended down almost 3% after the report. Thursday would be ABT's fourth straight day of losses.
Deal expected to close in the second quarter of 2026
Including the deal related rallies, shares in EXAS up ~80% YTD, while ABT up ~10% YTD
Related Articles
Elon Musk’s SpaceX Poised for Record-Breaking IPO: How Can Retail Investors Get In on the Action of Starlink Stock?
TradingKey - Elon Musk's rocket manufacturer SpaceX is expected to launch an IPO in 2026, with a target IPO valuation projected to reach $1.5 trillion. However, prior to its listing, the stock can only be traded in the private market, characterized by low information transparency and high capital ba
Cathie Wood Predicts Bitcoin Has Bottomed. Is Now The Best Time to Buy? How to Buy BTC?
Purchasing Bitcoin is generally divided into three stages: pre-transaction, during transaction, and post-transaction. Each stage requires careful attention, as losses can easily arise from operational errors, pitfalls, and other factors.
Musk’s Next Ambition: Building a Space-Based AI Data Center
TradingKey - Musk has long resisted the idea of taking SpaceX public. After the Tesla take-private drama and the resulting SEC penalties (which cost him the chairmanship), he’s been wary of public market entanglements. But something’s changed—and fast.
Japan Central Bank Rate Hike To Three-Decade High Imminent, How Will The Market Go? Which Assets Most Affected?
As global monetary policy divergence enters a critical phase, the Bank of Japan (BoJ) is anticipated to raise its benchmark interest rate at the monetary policy meeting on December 19, 2025, by 25 basis points to 0.75% , marking its highest level in nearly 30 years.
